title: Reply to Davido and Dinh.
authors.affiliation: Department of Infectious Diseases, Austin Health, Melbourne Department of Medicine, University of Melbourne, Australia.
authors.forename: M Lindsay
authors.initials: ML
authors.lastname: Grayson
authors.affiliation: Department of Infectious Diseases, Austin Health, Melbourne.
authors.forename: Nenad
authors.initials: N
authors.lastname: Macesic
authors.affiliation: Department of Infectious Diseases, Austin Health, Melbourne.
authors.forename: Janine
authors.initials: J
authors.lastname: Trevillyan
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005578:Fosfomycin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011472:Prostatitis / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D005578:Fosfomycin